Qlaira Regulatory Post Marketing Surveillance Study in Korea
Phase of Trial: Phase IV
Latest Information Update: 10 Apr 2019
At a glance
- Drugs Estradiol valerate/dienogest (Primary)
- Indications Menorrhagia; Pregnancy
- Focus Adverse reactions
- Sponsors Bayer
- 15 May 2018 Status changed from active, no longer recruiting to completed.
- 16 Apr 2018 Planned End Date changed from 6 Apr 2018 to 2 May 2018.
- 10 Aug 2017 Status changed from recruiting to active, no longer recruiting.